Enantioselective Catalytic Chlorosilane Reactions

Information

  • Research Project
  • 10046812
  • ApplicationId
    10046812
  • Core Project Number
    R15GM139087
  • Full Project Number
    1R15GM139087-01
  • Serial Number
    139087
  • FOA Number
    PAR-18-714
  • Sub Project Id
  • Project Start Date
    8/1/2020 - 4 years ago
  • Project End Date
    7/31/2023 - a year ago
  • Program Officer Name
    YANG, JIONG
  • Budget Start Date
    8/1/2020 - 4 years ago
  • Budget End Date
    7/31/2023 - a year ago
  • Fiscal Year
    2020
  • Support Year
    01
  • Suffix
  • Award Notice Date
    7/22/2020 - 4 years ago

Enantioselective Catalytic Chlorosilane Reactions

Hypervalent silicon complexes generated from Lewis base catalysts and chlorosilanes are very reactive intermediates and continue to be an important source for the development of new chemical methodologies in organic synthesis. The unique reactivity profiles, non-toxicity and ready availability of chlorosilanes have yielded an impressive array of chemical methods and processes. This proposal seeks to innovate the ability of chlorosilanes to deliver carbon nucleophiles under Lewis base catalysis conditions through integrated experimental and computational investigations, and to apply it to novel condensation reactions with readily available non-activated ketones and ketimines. These challenging transformations will be rendered enantioselective through the development of conceptually new classes of chiral Lewis base catalysts. The utility of the resulting methods will be demonstrated by the asymmetric synthesis of pharmaceuticals and biologically relevant molecules. Goals of the research program include advancing Lewis base catalysis of chlorosilanes at the fundamental level, and new reaction development that will provide rapid, efficient access to novel chiral building blocks bearing the oxygen- and nitrogen-substituted quaternary stereocenters. We will focus on the transformations that can provide chiral synthetic intermediates that are either inaccessible or very difficult to obtain with currently available methods. The results are expected to transform the way chlorosilanes are utilized in asymmetric synthesis.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R15
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
    300000
  • Indirect Cost Amount
    134610
  • Total Cost
    434610
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIGMS:434610\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    SBCA
  • Study Section Name
    Synthetic and Biological Chemistry A Study Section
  • Organization Name
    FLORIDA INSTITUTE OF TECHNOLOGY
  • Organization Department
    CHEMISTRY
  • Organization DUNS
    053396669
  • Organization City
    MELBOURNE
  • Organization State
    FL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    329016975
  • Organization District
    UNITED STATES